Send a Private Message
Follow This Member
Read Last 50 Messages
Ignore This Member
RSS Feed
Give a Gift Subscription

Search Member Posts


| Sort By: Ticker | Board | Date
Ticker  Board News Price Change Chg%   Added
My PLX Pitch: "Huge potential:

Protalix's development pipeline consists of proprietary versions of recombinant therapeutic proteins that target established pharmaceutical markets, including the following product candidates: pegunigalsidase alfa, a modified version of the recombinant human a–Galactosidase–A prot"
RDHL  RedHill Biopharma Ltd.7.35-0.02-0.27%   08/11/2020
My RDHL Pitch: "Huge potential:
RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases. RedHill promotes the gastrointestinal drugs, Movantik® for opioid-induced constipation in adults3, Talicia® for the treatment of Helicobacter pylori (H. pyl"
BVXV  BIONDVAX PHARMACUETICALS LTD3.620.020.56%   08/11/2020
My BVXV Pitch: "Last of 12,400 Participants Completes Final Visit in BiondVax's M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial"
BCLI  BrainStorm Cell Therapeutics Inc.   08/11/2020
My BCLI Pitch: "Phase 3 ALS Data Expected by the End of November 2020…"
KMDA  Kamada6.96-0.27-3.73%   06/30/2020
GMDA  Gamida Cell Ltd.   05/12/2020
My GMDA Pitch: "Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies

Business Wire•May 12, 2020

— Study met primary endpoint of time to neutrophil engraftment —
— Omidubicel represents potential transformative treatment o"
CANF  Can-Fite BioPharma1.85-0.04-2.12%   11/11/2013
* Market data is delayed 15-20 minutes.

Direct Link

Consent Preferences